LENS Landscape, a series of Systematic literature reviews built using LENS

Curo’s LENS Landscape is an intuitive, web-based, structured literature review application assessing clinical effectiveness, QoL insights which are updated regularly and available for immediate subscription.

Want to know more about subscribing to LENS Landscape?
Fill in your details below and we’ll email you instructions to view an online demonstration of LENS Landscape

Your privacy is important to us.
We will never share your personal details

LENS Landscape
  • Curo’s proprietary, powerful interactive LENS technology enables users to access and navigate this dynamically updating data set to develop insights around both mutation subgroups
  • Allows HE teams to assess the BoD landscape in these mutations and understand how their assets will land within rapidly evolving environments
  • LENS Landscapes can seamlessly evolve to full HTA SLR with inclusion of economic endpoints, wider grey literature and peer-reviewed sources
Schedule a demo

The first application in the series comprises a world class SLR covering clinical and humanistic endpoints in NSCLC patients with ALK and/or EGFR mutations.

LENS Landscape:
Non-Small Cell Lung Cancer (NSCLC)

  • Approximately 80 papers at launch
  • SLR updated every 6 months
  • All therapies across prospective clinical trials in ALK and/or EGFR mutations over the last 5 years
  • Simple subscription model on short or long terms basis

Systematic literature reviews (SLRs) provide the most reliable evidence for decision making in health care. They use a highly structured process to identify, appraise and synthesise all evidence relevant to a specific health care question.

  • SLRs are the cornerstone of all new medical research and health policy ensuring that the best available evidence is used to inform decisions in health and care services
  • The average time from protocol to publication at Cochrane is 23 months
  • At Curo, systematic reviews are conducted to conform to published guidelines issued by the Cochrane Collaboration and the PRISMA statements
Talk to us about subscribing
Contact us

For a no-obligation discussion about any of our services, or to arrange a demonstration of our Payer communication tools

Back to top